| |
Latest 10 SEC filings (by transaction date) for VXRT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 1/24 | Mar 28/24 | Tucker Sean | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,902 | $1.30 |
Apr 1/24 | Mar 28/24 | Cummings James F. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,292 | $1.30 |
Mar 20/24 | Mar 20/24 | Lo Steven | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 20/24 | Mar 18/24 | Tucker Sean | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Mar 20/24 | Mar 18/24 | Tucker Sean | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 90,000 | |
Mar 20/24 | Mar 18/24 | Lee Phillip E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Mar 20/24 | Mar 18/24 | Lee Phillip E | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 90,000 | |
Mar 20/24 | Mar 18/24 | Cummings James F. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Mar 20/24 | Mar 18/24 | Cummings James F. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 90,000 | |
Mar 20/24 | Mar 18/24 | Berg Edward B | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for VXRT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 1/24 | Mar 28/24 | Tucker Sean | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,902 | $1.30 |
Apr 1/24 | Mar 28/24 | Cummings James F. | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,292 | $1.30 |
Mar 20/24 | Mar 18/24 | Tucker Sean | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Mar 20/24 | Mar 18/24 | Tucker Sean | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 90,000 | |
Mar 20/24 | Feb 2/24 | Tucker Sean | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -9,220 | $1.20 |
Mar 20/24 | Dec 8/23 | Tucker Sean | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -34,288 | $0.710 |
Mar 20/24 | Mar 28/23 | Tucker Sean | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,683 | $0.750 |
Mar 20/24 | Mar 18/24 | Lee Phillip E | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 410,000 | |
Mar 20/24 | Mar 18/24 | Lee Phillip E | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 90,000 | |
Mar 20/24 | Dec 15/23 | Lee Phillip E | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -5,943 | $0.630 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |